Category Archives: Uncategorized

Obesity and Cancer Risk

“Shocking but true: according a new poll, only 7% of Americans understand that being obese increases a person’s cancer risk. This level of ignorance spells tragedy, for being overweight and obese not only boosts your risk of developing cancer, it also reduces your survival after a successful cancer treatment. But there’s hope: Go Mediterranean!“

 

Despite Obamacare, Health Insurance Premiums Rising

“Although one goal of the Affordable Care Act (ACA) was to rein in the high cost of health insurance, dozens of health plans continued to implement double-digit rate hikes.”

Mail In Spit To Learn Your Risk of Future Disease

23andMe is one of several companies offering genetic testing that estimates your future risk of various gene-related diseases.  I have no opinion yet on whether the testing is valid or not.  An article at MIT Technology Review will introduce you to the concept.  Cost for the test is $99 (USD) plus $10 shipping.  I’m not sure I want to share my genes with anyone but my children.

Dr. Freedhoff’s Review of Marla Heller’s “DASH Diet”

The DASH diet is well-established as an approach to control high blood pressure, and it tends to improve other metabolic markers of heart disease risk.  If memory serves me, there are  low-sodium and regular-sodium versions.

I’d never heard of a low-carb DASH diet before.  Click for review.

Link

Beta Blocker Blood Pressure Pills May Decrease Risk of Dementia

Beta Blocker Blood Pressure Pills May Decrease Risk of Dementia

Beta-blockers seemed to reduce the risk of dementia and Alzheimer’s disease, according to a study in older Japanese-American men.

Study Finds Low-Carb Diet Reduces Heart Disease Risk Factors

Obesity Reviews just published details of a recent meta-analyis of low-carbohydrate diet effects on cardiovascular risk factors.

A systematic review and meta-analysis were carried out to study the effects of low-carbohydrate diet (LCD) on weight loss and cardiovascular risk factors (search performed on PubMed, Cochrane Central Register of Controlled Trials and Scopus databases). A total of 23 reports, corresponding to 17 clinical investigations, were identified as meeting the pre-specified criteria.

Over a thousand obese patients were involved.  By eating low-carb, blood pressure dropped by 3–4 mmHg, average body weight decreased by 7 kg (15 lb), body mass index dropped by 2, triglycerides decreased by 30 mg/dl, hemoglobin A1c dropped by 0.21% (absolute decrease), insulin levels fell by 2.23 micro IU/ml, while HDL cholesterol rose by 1.73 mg/dl.  LDL cholesterol didn’t change.

The authors conclusion:

Low-carboydrate diet was shown to have favourable effects on body weight and major cardiovascular risk factors; however the effects on long-term health are unknown.

I haven’t see the full text of the article yet, so I don’t know the carbohydrate level under review.  I bet it’s under 50 g of digestible carb daily.  My Low-Carb Mediterranean Diet starts at 20-30 grams a day.

Steve Parker, M.D.

Reference:  Santos, F.L., et al. Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors. Obesity Reviews. Article first published online: 20 AUG 2012. DOI: 10.1111/j.1467-789X.2012.01021.x

Ever Heard of Farmageddon?

Tom Naughton of Fat Head fame reviewed a 2011 film called Farmageddon.  You might be interested.  Here’s how he starts off:

Chareva and I watched an excellent documentary over the weekend.  Farmageddon is a look at how our federal and state governments are beating up on small farmers who sell real food directly to the public.  If you still believe the fiction that we live in a free country, this film should change your mind.

Read the rest here.

-Steve

Informercial Superstar Found In Contempt of Court

Kevin Trudeau, author of The Weight Loss Cure “They” Don’t Want You to Know About and numerous other books, has been in trouble with the law over many years.

The twice-convicted felon was banned in 2004 from using infomercials to sell most products except for books and other publications.  The exception required that he not make false claims in infomercials.  The 2004 settlement regarding false claims also required him to pay $2 million.

Informercials for the aforementioned book began running in 2006.  In the commercials, Trudeau claims that his weight-loss plan is easy, simple, and you can do it at home.  “When you’re done, eat whatever you want and you don’t gain weight back.”

In reality, the book describes a complicated system involving daily intramuscular injections of human chorionic gonadotrophin (HCG), a prescription drug not approved by the U.S. FDA for weight loss.  You’ll have great difficulty finding a U.S. physician willing to prescribe this.  (The FDA last year told HCG marketers to cease and desist.)  The plan involves specialized cleanses and supplements.  One phase involves eating only 500 calories per day for 21 to 45 days, which is considered severe caloric restriction even for someone on a diet.  (Most people eat 1,500-2,5000 cal/day to maintain weight.)  Trudeau recommends 15 “colonics”  from a licensed colon therapist.  The book lists severe dietary prohibitions for life.

Trudeau’s felony convictions were in the 1990s: depositing bad checks, and credit card fraud.

On November 16, 2007, U.S. District Court Judge Robert W. Gettleman found Trudeau in comtempt of court for violating the 2004 injunction.

Trudeau’s Weight Loss Cure made it onto bestseller lists of the New York Times, the Wall Street Journal, and USA Today.

Go figure.

Steve Parker, M.D.

References:

FTC, plaintiff v. Kevin Trudeau et al, FTC news release 9/14/07

U.S. District Court for Northern District of Illinois, Eastern Division, File # 032 3064, Civil Actions # 03 C3904 and 98-C-0168.

Science In Support of the Mediterranean Diet

Atherosclerosis is the formal term for “hardening of the arteries.”  Who cares how hard they are, as long as the arteries deliver blood to our organs, right?

Atherosclerosis in the arteries that supply blood to the heart – essentially a hollow muscle that pumps blood – is called coronary heart disease disease (CHD) or coronary artery disease (CAD).

LDL cholesterol is the “bad cholesterol” that is associated with atherosclerosis.  Generally, the higher the LDL, the worse the atherosclerotic complications: plaque build-up leads to poor circulation to vital organs, arterial blood clots, even death of tissue due to blocked arteries.  Oxidation of LDL cholesterol facilitates atherosclerosis.

People at high risk for coronary heart disease include type 2 diabetics, smokers, people with high blood pressure or cholesterol abnormalities, and people with a family history of coronary heart disease.  Advanced age is another strong risk factor.

The ongoing PREDIMED Study is designed to test the the effects of the traditional Mediterranean diet in primary prevention of coronary heart disease in a high risk population.  9000 study participants will be assigned to one of three diets:  1) low-fat, 2) Mediterranean plus extra olive oil, or 3) Mediterranean plus extra nuts.  The Mediterranean diet is moderate in percentage of calories derived from fat, and the main source of fat is olive oil.  Virgin olive oil has a particularly high content of antioxidant phenolic compounds.  Nuts are also a rich source of antioxidant phytochemicals.  These antioxidants can prevent the harmful transmogrification of plain LDL into oxidized LDL.

A group of 372 early study enrollees were randomly assigned to one of the three diet groups.  In both of the Mediterranean diet groups, researchers found reduced oxidized LDL, reduced blood pressures, lower total cholesterol, and lower total-HDL cholesterol ratios, more than in the low-fat diet group.

These observed changes would tend to reduce the incidence and severity of atherosclerotic complications.  When PREDIMED is completed, we’ll know whether the traditional Mediterranean diet, compared with a low-fat diet, is better at preventing death and disease from coronary heart disease.  That’s where the rubber meets the road.

Steve Parker, M.D.

References:

Montserrat, Fito, et al.  Effect of a Traditional Mediterranean Diet on Lipoprotein Oxidation: A Randomized Controlled Trial.  Archives of Internal Medicine, 167 (2007): 1,195-1,203.

Prevencion con Dieta Mediterranea Study (PREDIMED)  http://www.predimed.org

Alcohol Habit (Especially Wine) Starting in Middle-Age Reduces Heart Attack and Stroke

Jesus turned water into wine at a wedding.  His mother asked him to do it.  Of all the miracles he performed and could have performed, I wonder why this is the first one recorded in the Holy Bible.

We have known for years that low or moderate alcohol consumption tends to lower the risk of cardiovascular disease such as heart attack and stroke, and prolongs life span.  Physicians have been hesitant to suggest that nondrinkers take up the habit.  We don’t want to be responsible for, or even accused of, turning someone into an alcoholic.  We don’t want to be held accountable for someone else’s drunken acts.  Every well-trained physician is quite aware of the ravages of alcohol use and abuse.  We see them up close and personal in our patients.

A scientific study from a few years ago, however, lends support to a middle-aged individual’s decision to start consuming moderate amounts of alcohol on a regular basis.  It even provides a positive defense if a doctor recommends it to carefully selected patients.

This research, by the way, was supported by a grant from the National Heart, Lung, and Blood Institute, not the wine/alcohol industry.

Methodology

Researchers at the Medical University of South Carolina examined data on 15,637 participants in the Atherosclerosis Risk in Communities (ARIC) study over a 10-year period.  These men and women were 45 to 64 years old at the time of enrollment, living in four communities across the U.S.  Of the participants, 27% were black, 73% nonblack, 28% were smokers, and 80% of them had high blood pressure, high cholesterol, or diabetes.

Out of 15,637 participants at the time of enrollment, 7,359 indicated that they didn’t drink alcohol.  At baseline, these 7,359 had no cardiovascular disease except for some with high blood pressure.    Subsequent interviews with them found that six percent of the nondrinkers – 442 people – decided independently to become moderate alcohol drinkers.  Or at least they identified themselves as such.

“Moderate” intake was defined as 1-14 drinks per week for men, and 1-7 drinks a week for women.  Incidentally, 0.4% of the initial non-drinking cohort – 21 people – became self-identified heavy drinkers.

93.6% of the 7,359 non-drinkers said that they continued to be non-drinkers.  These 6,917 people are the “persistent nondrinkers.”

Type of alcohol consumed was also surveyed and broken down into 1) wine-only drinkers, or 2) mixed drinkers: beer, liquor, wine.

Researchers then monitored health outcomes for an average of 4 years, comparing the “new moderate drinkers” with the “persistent nondrinkers.”

Results

  •  Over 4 years, 6.9% of the new moderate drinkers suffered a cardiovascular event, defined as a heart attack, stroke, a coronary heart disease procedure (e.g, angioplasty), or death from cardiovascular disease.
  • Over 4 years, 10% of the persistent nondrinkers suffered a cardiovascular event.
  • The new moderate drinkers were 38% less likely than persistent nondrinkers to suffer a new cardiovascular event (P = 0.008, which is a very strong association).  The difference persisted even after adjustment for demographic and cardiovascular risk factors.
  • There was no difference in all-cause mortality (death rate) between the new moderate drinkers and the persistent nondrinkers.
  • New  drinkers had modest but statistically significant improvements in HDL and LDL cholesterol and mean blood pressure compared with persistent nondrinkers.
  • 133 new moderate drinkers consumed only wine
  • 234 new moderate drinkers consumed mixed types of alcohol
  • Wine-only drinkers were 68% less likely than nondrinkers to suffer a cardiovascular event.
  • “Consumers of moderate amounts of beer/liquor/mixed (which includes some wine) tended to also be less likely to have had a subsequent cardiovascular event than nondrinkers…but the difference was not significant.”

A Few Study Limitations

  • Four years is a relatively brief follow-up, especially for cancer outcomes.  Alcohol consumption is associated with certain types of cancer.
  • If moderate alcohol consumption indeed lowers death rates as suggested by several other studies, this study may not have lasted long enough to see it.
  • The alcohol data depended on self-reports.

Take-Home Points

The study authors cite four other studies that support a slight advantage to wine over other alcohol types.  It’s a mystery to me why they fail to stress the apparent superiority of wine in the current study.  Several other studies that found improved longevity or cardiovascular outcomes in low-to-moderate drinkers suggest that the type of alcohol does not matter.  Perhaps “the jury is still out.”  In the study at hand, however, it is clear that the reduced cardiovascular disease rate in new moderate drinkers is associated with wine.

In all fairness, other studies show no beneficial health or longevity benefit to alcohol consumption.  But at this point, the majority of published studies support a beneficial effect.

Wine is a component of the traditional healthy Mediterranean diet.  The Mediterranean diet is associated with prolonged life span and reduced cardiovascular disease.  This study strongly suggests that wine is one of the causative healthy components of the Mediterranean diet.

Starting a judicious wine habit in middle age is relatively safe for selected people and may, in fact, improve cardiovascular health, if not longevity.

Now the question is, red or white.  Or grape juice?

Steve Parker, M.D.

Reference:  King, Dana E., et al.  Adopting Moderate Alchohol Consumption in Middle Age: Subsequent Cardiovascular Events.  American Journal of Medicine, 121 (2008): 201-206.